Le Lézard
Classified in: Health
Subject: PER

BioPlus Specialty Pharmacy Announces New President: Mark Montgomery


ALTAMONTE SPRINGS, Fla., Sept. 19, 2018 /PRNewswire-PRWeb/ -- BioPlus Specialty Pharmacy (BioPlus), one of the nation's leading innovative specialty pharmacies, announces today that Mark Montgomery has joined the company in the position of President. Stephen Vogt, Pharm.D., who previously held the dual position of both CEO and President, will continue in his role as CEO.

"Adding Mark as the new President of BioPlus comes at an exciting time for BioPlus as our company has been experiencing stellar growth and expansion within the specialty pharmacy field," shares Dr. Vogt. "With his proven leadership in the industry, I'm confident that he'll be instrumental in bringing our dynamic and growing company to yet another level in terms of our development and implementation of growth strategies at BioPlus."

Montgomery brings 25 years of specialty pharmacy experience to BioPlus, as evidenced by earning a spot on Specialty Pharmacy Times' Top 30 Influential Persons in Specialty Pharmacy in 2011 and being named a Healthcare Entrepreneur of the Year in 2012 by Ernst & Young. "I have admired BioPlus for their patient-centric care and as a leading independent national specialty platform for the industry. I look forward to working with all of the great professionals BioPlus already has onboard," says Montgomery.

Previously Montgomery built Axium Healthcare Pharmacy into a leading national specialty pharmacy and shepherded its successful sale in 2012 to the Kroger organization. He is also a founder and past board member of the National Association of Specialty Pharmacies.

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 29 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for cancer, multiple sclerosis, hepatitis C, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: http://www.bioplusrx.com or
Contact: info(at)bioplusrx.com
Phone: 1-888-292-0744

 

SOURCE BioPlus Specialty Pharmacy


These press releases may also interest you

at 07:50
Peptide Synthesis Market Trends and Global Analysis Report 2024: Demand for GLP-1 Peptide API Contract Manufacturing has Increased Significantly - Forecasts to 2035 - ResearchAndMarkets.com
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...

at 07:45
Global Laboratory Filtration Equipment Research Report 2023-2030 - Increase in Vaccine Production, Bioburden Control in a Booming Biopharmaceutical Industry Spurs Opportunities - ResearchAndMarkets.com
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:40
Global Weight Loss Drugs Markets Report 2023-2024 & 2029 - The Emergence of GLP-1 and GIP, Unmet Market Needs and Emerging Product Pipeline - ResearchAndMarkets.com
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
AbbVie Reports First-Quarter 2024 Financial Results
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...

at 07:30
INTEGRAcare Inc. has been named as #1 Best Workplace in Healthcare in Canada & the 5th Best Workplace in Canada (across all industries) in 2024 by Great Place to Work®
During an awards ceremony to present the 2024 list of Best Workplacestm in Canada, Great Place to Work® announced the 50 Best Workplacestm in Canada with 100-999 employees....

More news about Health...


News published on and distributed by: